DeepMed Research

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

GSK-1292263

Generic Name: GSK-1292263

Drug Type: Small Molecule

Chemical Formula: C_₂₃H_₂₈N_₄O_₄S

CAS Number: 1032823-75-8

Unique Ingredient Identifier: R1J57STA6O

Overview

GSK1292263 has been investigated for the treatment of DIABETES MELLITUS, TYPE 2.

Background

GSK1292263 has been investigated for the treatment of DIABETES MELLITUS, TYPE 2.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

A Study in Type 2 Diabetic Subjects on Stable Metformin Therapy to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Co-administering Single and Multiple Oral Doses of GSK1292263

Phase 2

Completed

Posted: 2010/05/24

Sponsor:GlaxoSmithKline

A Study in Type 2 Diabetics of Single and Multiple Doses of Orally Administered GSK1292263 to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics

Phase 2

Completed

Posted: 2010/05/10

Sponsor:GlaxoSmithKline

A Study to Investigate the Interaction of GSK1292263 With Rosuvastatin and Simvastatin in Healthy Subjects

Phase 1

Completed

Posted: 2010/04/12

Sponsor:GlaxoSmithKline

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Related News

No news found

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy